Share This Author
Basic properties and molecular mechanisms of exogenous chemical carcinogens.
It is concluded that ECCs could be major contributors to human cancer, with obviously great public health consequences, because of these molecular properties and action mechanisms.
Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.
Pretreatment with amifostine reduces the cumulative hematologic, renal, and neurologic toxicities associated with the CP regimen, with no reduction in antitumor efficacy.
Lifestyle-related factors and environmental agents causing cancer: an overview.
The multitude and diversity of environmental carcinogens.
Reliable disease biomarkers characterizing and identifying electrohypersensitivity and multiple chemical sensitivity as two etiopathogenic aspects of a unique pathological disorder
Preliminary data suggest that EHS and MCS can be objectively characterized and routinely diagnosed by commercially available simple tests and strongly suggest a common pathological mechanism.
Thermal and non-thermal health effects of low intensity non-ionizing radiation: An international perspective.
Overweight/obesity and cancer genesis: more than a biological link.
Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis
Findings reinforce the cumulative evidence pointing to hyperglycemia as a risk factor for cancer incidence and bring renewed interest in MG scavengers for cancer treatment.
Environment as a Potential Key Determinant of the Continued Increase of Prostate Cancer Incidence in Martinique
The incidence rate of prostate cancer in Martinique is one of the highest reported worldwide; it is continuously growing since 1985 in an exponential mode, and despite a similar screening detection process and lifestyle-related behaviour, it is constantly at a higher level than in metropolitan France.
Advanced epithelial ovarian cancer: 1993 consensus statements.
This article reports on the statements written by the chairmen and approved by the consensus group, which achieved consensus on a number of issues with implications for standard practice and for research.